Table 2.
Effects of digital health technology interventions on medication adherence and clinical tuberculosis outcomes.
| No. | First author, year of publication | Interventiona | Medication adherence outcome (95% CI) | Clinical outcome (95% CI) |
|
||||
|
|
Treatment completion |
Treatment adherence |
Missed doses |
Noncompleted rate | Cure rate | Smear sputum conversion | |||
| 1 | Story et al, 2019 [20] | VOTb | ORc: 2.52 (1.17-5.54) | N/Ad | N/A | N/A | N/A | N/A | |
| 2 | Chuck et al, 2016 [21] | VDOTe | RRf: 0.99 (0.93-1.05) | N/A | N/A | N/A | N/A | N/A | |
| 3 | Lam et al, 2018 [22] | VDOT | RR: 1.36 (1.19-1.55) | N/A | N/A | N/A | N/A | N/A | |
| 4 | Chen et al, 2020 [24] | VDOT | N/A | RR: 1.08 (0.89-1.32) | N/A | N/A | N/A | N/A | |
| 5 | Kunawararak et a., 2011 [30] | Phone call reminder | N/A | N/A | N/A | N/A | RR: 1.30 (1.07-1.59) | N/A | |
| 6 | Liu et al, 2015 [18] | SMS, medication monitor box, and combined | N/A | N/A | MRg: 0.94 (0.71-1.24) MR: 0.58 (0.42-0.79) MR: 0.49 (0.27-0.88) |
N/A | N/A | N/A | |
| 7 | Moulding & Caymittes, 2002 [31] | Medication monitor with counseling | N/A | N/A | N/A | RR: 0.55 (0.21-1.42) | N/A | N/A | |
| 8 | Browne et al, 2019 [23] | Ingestible sensor | OR: 7.69 (4.51-14.48) | N/A | N/A | N/A | N/A | N/A | |
| 9 | Fang et al, 2017 [25] | SMS reminder | RR: 1.10 (1.04-1.18) | N/A | RR: 0.40 (0.11-1.50) | N/A | N/A | N/A | |
| 10 | Mohammed et al, 2016 [26] | SMS reminder | RR: 1.00 (0.79–1.26) | N/A | N/A | N/A | N/A | RR: 1.00 (0.90–1.12) | |
| 11 | Belknap et al, 2017 [9] | SMS reminder | RR: 0.87 (0.81-0.94) | N/A | N/A | N/A | N/A | N/A | |
| 12 | Bediang et al., 2018 [28] | SMS reminder | OR: 1.45 (0.81-2.56) | N/A | N/A | N/A | OR: 1.06 (0.65-1.73) | N/A | |
| 13 | Johnston et al, 2018 [10] | SMS reminder | RR: 0.97 (0.88-1.07) | N/A | N/A | N/A | N/A | N/A | |
| 14 | Iribarren et al, 2013 [29] | SMS reminder | RR: 0.99 (0.93-1.05) | RR: 1.05 (1.04-1.06) | N/A | N/A | N/A | N/A | |
| 15 | Ali & Martin, 2019 [17] | SMS reminder | N/A | N/A | N/A | OR 1.67 (0.52-5.37) | OR: 2.47 (1.13-5.43) | N/A | |
| 16 | Farooqi et al, 2017 [27] | SMS reminder | N/A | N/A | N/A | RR: 0.76 (0.18-3.28) | RR: 1.05 (0.62-1.76) | N/A | |
aThe comparison group is provided in Table 1.
bVOT: video-observed therapy.
cOR: odds ratio.
dN/A: not applicable.
eVDOT: video directly observed therapy.
fRR: relative risk.
gMR: mean ratio.